Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Generate Biomedicines, Inc. (NASDAQ: GENB)
GENB Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-6.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
97.80%
GENB Stock Analysis
GENB
PE Ratio:
GENB
PEG Ratio:
Not Available
GENB
Forward EPS Growth (12 month):
0.00%
GENB
PS Ratio:
51.9
GENB
PSG Ratio:
4.7
GENB
Forward Revenue Growth (12 month):
11.00%
GENB Articles
No data was found